The Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.


The Cure Starts Now has funded $23,514,997 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 149 grants at over 100 hospitals in 17 countries.




DIPG Registry - $219,000

Amount
$219,000.00
Date
January 2012

Establishment of an International DIPG Registry

Texas Children's Cancer Center - $100,000

Amount
$100,000.00
Date
November 2011

Eliminating Therapy-Resistant Diffuse Intrinsic Pontine Gliomas with Oncolytic Picorna Virus SVV-001

Duke University - $82,049

Amount
$82,049.00
Date
November 2011

Preclinical Evaluation of Systemic and Direct Delivery of a PDGFR-Alpha Antibody

Doernbecher Children's Hospital - $100,000

Amount
$100,000.00
Date
November 2011

Rapid Preclinical Development of a Targeted Therapy Combination for DIPG.

Sydney Children's Hospital - $100,000

Amount
$100,000.00
Date
August 2011

Robotic screening for novel therapies for diffuse pontine gliomas

St. Jude's Children's Research Hospital - $35,000

Amount
$35,000.00
Date
September 2010

PI3K signaling effectors in DIPG

Cincinnati Children's Hospital - $35,000

Amount
$35,000.00
Date
September 2010

Establishment of a pre-clinical model for pediatric glioblastoma

Cincinnati Children's Hospital - $75,000

Amount
$75,000.00
Date
March 2010

Telomerase: A Therapeutic Target in Pediatric Brain Tumors

Weill Cornell Medical College - $91,740

Amount
$91,740.00
Date
March 2010

Phase I Study of tumor-targeting Convection-Enhanced Delivery (CED) of radio immunotherapy for Diffuse Pontine Glioma in Children.

St. Jude's Children's Research Hospital - $10,000

Amount
$10,000.00
Date
July 2009

Molecular Analysis of Diffuse Intrinsic Pontine Gliomas.

Cincinnati Children's Hospital - $50,000

Amount
$50,000.00
Date
July 2009

National expansion of the study of Radiotherapy and concurrent Bevacizumab +/- Temozolamide followed by Bevacizumab, Irinotecan +/- Temozolamide in patients with newly diagnosed high grade gliomas and DIPG.

St. Jude's Children's Research Hospital - $50,000

Amount
$50,000.00
Date
July 2009

Phase I Study of the combination of Vandetanib and Dasatinib administered during and after radiation therapy in the children with newly diagnosed DIPG.

Cincinnati Children's Hospital - $50,000

Amount
$50,000.00
Date
September 2008

Study of Radiotherapy and concurrent Bevacizumab +/- Temozolamide followed by Bevacizumab, Irinotecan +/- Temozolamide in patients with newly diagnosed high grade gliomas and DIPG.

St. Jude's Children's Research Hospital - $25,000

Amount
$25,000.00
Date
September 2008

Molecular Analysis of Diffuse Intrinsic Pontine Gliomas.